Samsung Medical Center
Seoul, 135-710, South Korea
NCT Number: NCT00815334
Endoscopic subureteral injection for vesicoureteral reflux has become an established alternative to ureter reimplantation in children. Some recent studies suggest that ESI can be also a primary treatment option for VUR in adults. However, the experience with ESI in adults who have VUR associated with decreased bladder compliance is limited. We evaluated the efficacy of endoscopic subureteral injection treatment for vesicoureteral reflux in adults with decreased bladder compliance.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Seoul, 135-710, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Endoscopic subureteric injection for the treatment of vesicoureteral reflux using variable materials (polydimethylsiloxane, collagen, and dextranomer/hyaluronic acid copolymer)
Time frame: 3, 12 months
Time frame: 3, 12 months
Time frame: 3, 12 months
Samsung Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00186199
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Stanford, California, United States
View Trial DetailsNCT01483105
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Palo Alto, California, United States
View Trial DetailsNCT00405704
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial DetailsNCT02786810
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Memphis, Tennessee, United States
View Trial Details